FDA Inspection 1142344 — Seattle Reproductive Medicine Inc P.S.

Seattle Reproductive Medicine Inc P.S. — FEI 3016678430

The FDA completed an inspection of Seattle Reproductive Medicine Inc P.S. on May 13, 2021 in Everett, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
May 13, 2021
Fiscal Year
2021
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Everett, WA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.